Edap Tms (FOCL) Research & Development (2009 - 2026)
Edap Tms' (FOCL) quarterly Research & Development came in at $7.1 million in Q1 2026, up 17.44% YoY from $6.1 million in Q1 2025, and down 79.58% on a QoQ basis from $34.9 million in Q4 2025.
Edap Tms (FOCL) Research & Development (2009 - 2026) Analysis & Trends
Edap Tms (FOCL) has 18 years of Research & Development data on file, last reported at $7.1 million in Q1 2026.
- Quarterly Research & Development rose 17.44% year-over-year to $7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.0 million (up 127844.83% YoY) and the FY2025 annual result came in at $27.3 million, changed 0.18% from the prior year.
- Research & Development retreated to $7.1 million in Q1 2026, from $34.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $34.9 million in Q4 2025 to a low of -$2.5 million in Q2 2025.
- A 5-year average of $1.4 million and a median of -$1.8 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development slumped 230.05% — and 2025, when it soared 1867.12%.
- Tracing FOCL's Research & Development over 5 years: stood at -$1.3 million in 2022, then plunged by 77.6% to -$2.4 million in 2023, then grew by 17.3% to -$2.0 million in 2024, then soared by 1867.12% to $34.9 million in 2025, then slumped by 79.58% to $7.1 million in 2026.
- The last three Research & Development figures came in at $7.1 million (Q1 2026), $34.9 million (Q4 2025), and -$2.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.60 Bn | 97.44 Bn | 3.69 Bn | - |
| 2 | Cencora | 61.76 Bn | 58.95 Bn | 3.61 Bn | - |
| 3 | Cardinal Health | 54.19 Bn | 49.33 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | - |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - | - |
| 6 | Edap Tms | 155.55 Mn | 134.01 Mn | 7.34 Mn | 7.54 Mn |
| 7 | Accendra Health | 93.18 Mn | 85.53 Mn | 263.41 Mn | - |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn | -8.41 Mn |
| 9 | Cosmos Health | 13.29 Mn | 10.85 Mn | 1.51 Mn | 98,226.00 |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.12 Mn |
| Dec 31, 2025 | 34.88 Mn |
| Sep 30, 2025 | -2.42 Mn |
| Jun 30, 2025 | -2.54 Mn |
| Mar 31, 2025 | 6.07 Mn |
| Dec 31, 2024 | -1.97 Mn |
| Sep 30, 2024 | -1.89 Mn |
| Jun 30, 2024 | -2.23 Mn |
| Mar 31, 2024 | -2.24 Mn |
| Dec 31, 2023 | -2.39 Mn |
| Sep 30, 2023 | -1.76 Mn |
| Jun 30, 2023 | -1.82 Mn |
| Mar 31, 2023 | -1.57 Mn |
| Dec 31, 2022 | -1.34 Mn |
| Sep 30, 2022 | -1.36 Mn |
| Jun 30, 2022 | -1.24 Mn |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | -640,000.00 |
| Sep 30, 2021 | -1.25 Mn |
| Jun 30, 2021 | -1.11 Mn |